Observational Study of Magnetoencephalography Use in Children Aged 1 Month to 18 Years With Neurodevelopmental Disorders

What this Trial Is About

Researchers are evaluating the use of magnetoencephalography MEG to diagnose various neurodevelopmental disorders in children. These conditions include epilepsy, intracranial tumors, cerebrovascular diseases, autism, mental retardation, attention deficit hyperactivity disorder ADHD, tic disorder, and other neuropsychiatric disorders. The study aims to observe how MEG can help locate epileptic regions and brain functional areas to support diagnosis in pediatric patients. This observational study involves children with neurodevelopmental diseases and healthy children as comparison groups. Participants undergo MEG, a non-invasive imaging technique that measures brain activity. The study does not involve experimental treatments but focuses on assessing MEGs diagnostic value. During the study, researchers will measure differences in MEG signals between affected children and healthy controls over three years. Participants will be monitored and evaluated through MEG exams, with attention to their ability to cooperate during the procedure. The study is conducted at a single center and spans from September 2024 to December 2027, with assessments aimed at better understanding MEGs role in diagnosing pediatric neurodevelopmental conditions.

Magnetoencephalography in Children